Department of Renal Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia; Internal Medicine, University of Western Australia Medical School, Perth, Western Australia.
School of Medicine, University of New South Wales, Sydney, New South Wales; Department of Renal Medicine, Wollongong Hospital, Wollongong, New South Wales.
Am J Kidney Dis. 2023 Feb;81(2):156-167.e1. doi: 10.1053/j.ajkd.2022.07.007. Epub 2022 Aug 25.
RATIONALE & OBJECTIVE: Early mortality rates of female patients receiving dialysis have been, at times, observed to be higher than rates among male patients. The differences in cause-specific mortality between male and female incident dialysis patients with kidney failure are not well understood and were the focus of this study.
Retrospective cohort study.
SETTING & PARTICIPANTS: Incident patients who had initiated dialysis in Australia and New Zealand in 1998-2018.
Sex.
Cause-specific and all-cause mortality while receiving dialysis, censored for kidney transplant.
Adjusted cause-specific proportional hazards models, focusing on the first 5 years following initiation of dialysis.
Among 53,414 patients (20,876 [39%] female) followed for a median period of 2.8 (IQR, 1.3-5.2) years, 27,137 (51%) died, with the predominant cause of death attributed to cardiovascular disease (18%), followed by dialysis withdrawal (16%). Compared with male patients, female patients were more likely to die in the first 5 years after dialysis initiation (adjusted hazard ratio [AHR], 1.08 [95% CI, 1.05-1.11]). Even though female patients experienced a lower risk of cardiovascular disease-related mortality (AHR, 0.93 [95% CI, 0.89-0.98]) than male patients, they experienced a greater risk of infection-related (AHR, 1.20 [95% CI, 1.10-1.32]) and dialysis withdrawal-related (AHR, 1.19 [95% CI, 1.13-1.26]) mortality.
Possibility of residual and unmeasured confounders.
Compared with male patients, female patients had a higher risk of all-cause mortality in the first 5 years after dialysis initiation, a difference driven by higher rates of mortality from infections and dialysis withdrawals. These findings may inform the study of sex differences in mortality in other geographic settings.
有时,接受透析治疗的女性患者的早期死亡率高于男性患者。导致肾衰竭的男性和女性透析患者的特定病因死亡率之间的差异尚不清楚,本研究对此进行了重点关注。
回顾性队列研究。
1998 年至 2018 年在澳大利亚和新西兰开始透析的新发病例患者。
性别。
接受透析治疗期间的特定病因和全因死亡率,并对肾移植进行了删失。
调整后的特定病因比例风险模型,重点关注透析开始后的前 5 年。
在中位时间为 2.8(IQR,1.3-5.2)年的 53414 例患者(20876[39%]名女性)中,有 27137 例(51%)死亡,主要死亡原因为心血管疾病(18%),其次为透析退出(16%)。与男性患者相比,女性患者在透析开始后的前 5 年更有可能死亡(调整后的危险比[HR],1.08[95%CI,1.05-1.11])。尽管女性患者发生心血管疾病相关死亡率的风险较低(HR,0.93[95%CI,0.89-0.98]),但她们发生感染相关(HR,1.20[95%CI,1.10-1.32])和透析退出相关(HR,1.19[95%CI,1.13-1.26])死亡率的风险更高。
可能存在残余和未测量的混杂因素。
与男性患者相比,女性患者在透析开始后的前 5 年内全因死亡率更高,这种差异主要是由于感染和透析退出导致的死亡率较高所致。这些发现可能有助于研究其他地理环境下的死亡率性别差异。